These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33480159)

  • 1. Fragment-Based Nuclear Magnetic Resonance Screen against a Regulator of G Protein Signaling Identifies a Binding "Hot Spot".
    Hayes MP; O'Brien JB; Crawford RA; Fowler CA; Yu L; Doorn JA; Roman DL
    Chembiochem; 2021 May; 22(9):1609-1620. PubMed ID: 33480159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.
    Hayes MP; Roman DL
    AAPS J; 2016 May; 18(3):550-9. PubMed ID: 26928451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel high-throughput screen and identification of small-molecule inhibitors of the Gα-RGS17 protein-protein interaction using AlphaScreen.
    Mackie DI; Roman DL
    J Biomol Screen; 2011 Sep; 16(8):869-77. PubMed ID: 21680864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution structure of RGS17 suggests a role for Ca
    Sieng M; Hayes MP; O'Brien JB; Andrew Fowler C; Houtman JC; Roman DL; Lyon AM
    J Biol Chem; 2019 May; 294(20):8148-8160. PubMed ID: 30940727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures.
    Bodle CR; Schamp JH; O'Brien JB; Hayes MP; Wu M; Doorn JA; Roman DL
    SLAS Discov; 2018 Apr; 23(4):363-374. PubMed ID: 29351497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma.
    Sokolov E; Iannitti DA; Schrum LW; McKillop IH
    Cell Signal; 2011 Oct; 23(10):1603-10. PubMed ID: 21620966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGS17: an emerging therapeutic target for lung and prostate cancers.
    Bodle CR; Mackie DI; Roman DL
    Future Med Chem; 2013 Jun; 5(9):995-1007. PubMed ID: 23734683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss.
    Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V
    Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling.
    Mao H; Zhao Q; Daigle M; Ghahremani MH; Chidiac P; Albert PR
    J Biol Chem; 2004 Jun; 279(25):26314-22. PubMed ID: 15096504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR methods for detection of small molecule binding to RGS4.
    Storaska AJ; Neubig RR
    Methods Enzymol; 2013; 522():133-52. PubMed ID: 23374184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
    Hooks SB; Callihan P; Altman MK; Hurst JH; Ali MW; Murph MM
    Mol Cancer; 2010 Nov; 9():289. PubMed ID: 21044322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGS17/RGSZ2 and the RZ/A family of regulators of G-protein signaling.
    Nunn C; Mao H; Chidiac P; Albert PR
    Semin Cell Dev Biol; 2006 Jun; 17(3):390-9. PubMed ID: 16765607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-Protein Signaling Protein-17 (RGS17) Is Upregulated and Promotes Tumor Growth and Migration in Human Colorectal Carcinoma.
    Li L; Luo HS
    Oncol Res; 2018 Jan; 26(1):27-35. PubMed ID: 28337960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational dynamics of a regulator of G-protein signaling protein reveals a mechanism of allosteric inhibition by a small molecule.
    Vashisth H; Storaska AJ; Neubig RR; Brooks CL
    ACS Chem Biol; 2013 Dec; 8(12):2778-84. PubMed ID: 24093330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0006220 promotes non-small cell lung cancer progression via sponging miR-203-3p and regulating RGS17 expression.
    Wang S; Zhang C; Chen R
    Hum Exp Toxicol; 2022; 41():9603271211062854. PubMed ID: 35041543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.
    Chi Y; Jin Q; Liu X; Xu L; He X; Shen Y; Zhou Q; Zhang J; Jin M
    Cancer Sci; 2017 Dec; 108(12):2366-2372. PubMed ID: 28921827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells.
    Thirunavukkarasu K; Halladay DL; Miles RR; Geringer CD; Onyia JE
    J Cell Biochem; 2002; 85(4):837-50. PubMed ID: 11968023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Protein Dynamics of Regulators of G-Protein Signaling: Role in Specificity of Small-Molecule Inhibitors.
    Shaw VS; Mohammadiarani H; Vashisth H; Neubig RR
    J Am Chem Soc; 2018 Mar; 140(9):3454-3460. PubMed ID: 29460621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-203 inhibits the malignant behavior of prostate cancer cells by targeting RGS17.
    Zhang LS; Ma HG; Sun FH; Zhao WC; Li G
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5667-5674. PubMed ID: 31298318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway.
    James MA; Lu Y; Liu Y; Vikis HG; You M
    Cancer Res; 2009 Mar; 69(5):2108-16. PubMed ID: 19244110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.